Literature DB >> 32519552

Assessment of the Relationship Between C-Reactive Protein-to-Albumin Ratio and the Presence and Severity of Isolated Coronary Artery Ectasia.

Seçkin Dereli1, İdris Buğra Çerik1, Ahmet Kaya1, Osman Bektaş1.   

Abstract

We investigated the relationship between C-reactive protein-to-albumin ratio (CAR) and coronary artery ectasia (CAE). The retrospective study population included 150 patients with isolated CAE, 150 with obstructive coronary artery disease (CAD), and 150 with a normal coronary artery angiogram (NCA). The severity of isolated CAE was determined according to the Markis classification. C-reactive protein-to-albumin ratio was significantly higher in patients with isolated CAE than in those with obstructive CAD and NCA (10.5 [5.9-30.9], 5.7 [1.8-13.2] and 3.0 [0.9-8.9], respectively). Logistic regression analysis showed that CAR (odds ratio [OR]: 3.054, 95% CI: 1.021-9.165, P = .001), platelet-to-lymphocyte ratio (PLR; OR: 1.330, 95% CI: 1.025-1.694, P = .044), and monocyte-to-high density cholesterol ratio (MHR; OR: 1.031, 95% CI: 1.009-1.054, P = .006) were independently associated with the presence of isolated CAE. Receiver operating characteristic curve analysis showed that CAR (area under the curve [AUC] ± standard error [SE] = 0.838 ± 0.016; P < .001) had a stronger diagnostic value for detecting significant CAE than PLR (AUC ± SE = 0.632 ± 0.023) and MHR (AUC ± SE = 0.726 ± 0.022). C-reactive protein-to-albumin ratio had a significantly strong correlation with the severity of isolated CAE (r = 0.536, P < .001). To the best of our knowledge, this study showed for the first time that CAR was significantly associated with CAE presence and severity.

Entities:  

Keywords:  C-reactive protein-to-albumin ratio; coronary artery ectasia; inflammatory markers

Year:  2020        PMID: 32519552     DOI: 10.1177/0003319720930983

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  6 in total

Review 1.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

Review 2.  Coronary Artery Ectasia: Review of the Non-Atherosclerotic Molecular and Pathophysiologic Concepts.

Authors:  Gavin H C Richards; Kathryn L Hong; Michael Y Henein; Colm Hanratty; Usama Boles
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

3.  Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.

Authors:  Xiaoliang Liu; Lin Wang; Kaiyu Zhou; Shuran Shao; Yimin Hua; Mei Wu; Lei Liu; Chuan Wang
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-12       Impact factor: 3.054

4.  Relationship between C-reactive protein to albumin ratio and Coronary Artery Calcium Score and CAD-RADS scores with Coronary Computed Tomography Angiography.

Authors:  Mehmet Akif Erdöl; Kadriye Gayretli Yayla
Journal:  Turk J Med Sci       Date:  2021-08-27       Impact factor: 0.973

Review 5.  Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma.

Authors:  Luca Esposito; Marco Di Maio; Angelo Silverio; Francesco Paolo Cancro; Michele Bellino; Tiziana Attisano; Fabio Felice Tarantino; Giovanni Esposito; Carmine Vecchione; Gennaro Galasso; Cesare Baldi
Journal:  Front Cardiovasc Med       Date:  2022-02-04

6.  High levels of C-reactive protein-to-albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage.

Authors:  Zishuai Liu; Rongling Zhang; Wei Zhou; Ruize Ma; Leqiang Han; Zhe Zhao; Ziruo Ge; Xingxiang Ren; Wei Zhang; Aijun Sun; Zhihai Chen
Journal:  J Med Virol       Date:  2022-07-14       Impact factor: 20.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.